FluMist trivalent cold-adapted intranasal influenza vaccine: AVIR and Australian marketing partner CSL Ltd. (ASX:CSL, Parkville, Australia) began a bridging stu

By WIR Staff | Dec 14, 1998 | 8:00 AM GMT

Aviron (AVIR), Mountain View, Calif.
Product: FluMist trivalent cold-adapted intranasal influenza vaccine

Read the full 120 word article

How to gain access

Continue reading with a
two-week free trial.